BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240422
DTEND;VALUE=DATE:20240425
DTSTAMP:20260515T233500
CREATED:20240125T115520Z
LAST-MODIFIED:20240125T115520Z
UID:38573-1713744000-1714003199@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes and Injectable Drug Devices East Coast Conference and Exhibition
DESCRIPTION:SAE Media Group’s 11th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2024 to bring you the latest advances in the combination product drug delivery space. The 2024 conference will be bigger and better than ever\, bringing you 3 days of expertise\, comprising of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference with morning keynote plenaries and parallel afternoon topic streams addressing the industry’s hottest topics through case studies and industry insights. \nThis event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in April 2024! \nWhy attend: \n\n3 full days of networking opportunities\n40+ presentations with 75% of speakers from the top 20 big pharma companies\nThe agenda has been curated by an advisory board of big pharma and biotech opinion leaders providing expertise focused on device development\, regulatory affairs and quality\nAccess a focus day and 4 dedicated streams addressing the hottest topics in the industry\n\nThis year’s agenda has been validated by our 2024 advisory board: \nJohn Schalago\, Executive Director\, Senior Global Program Director\, Novartis\nKhaudeja Bano\, Vice President\, Combination Product Quality\, Amgen\nJames P. Wabby\, Global Head\, Regulatory Affairs – Emerging Device Technologies and Combination Products\, AbbVie\nMark DeStefano\, Director\, Combination Products and Devices R&D\, Teva\nMichael Song\, Director\, Drug Product Development\, Moderna \nWhat you will gain: \n\nCollaborate with pharma\, biotech and device developers across 3 full days on the latest trends\, advancements and challenges within the pre-filled syringe and injectable device market\nHear about new technological advances for challenging to delivery drugs such as large volume\, highly viscous and lyophilised formulations with case studies on wearable injectors and more\nUnderstand the latest regulatory requirements from experts surrounding combination products and engage in opportunities for collaboration and needs for advancing innovation in the field with an advisory board fireside chat\nGain insight into how big pharma is incorporating sustainable approaches into drug device design and lifecycle management\nDelve into the growing potential of digital health to improve patient experience and treatment\, and the challenges facing its implementation\nExamine how container and packaging development can support the ever-evolving innovations drug development\, including case studies on CCIT in deep-cold storage and formulator perspectives\n\nTo know more visit: www.pfsamericas.com/PharmaJournalist-Event-Listing
URL:http://www.pharmajournalist.com/event/pre-filled-syringes-and-injectable-drug-devices-east-coast-conference-and-exhibition/
LOCATION:Boston\, USA
ORGANIZER;CN="SAE Media Group":MAILTO:events@saemediagroup.com
END:VEVENT
END:VCALENDAR